Table 3.
Composition of gemcitabine and gemcitabine prodrugs in Caco-2 cell uptake studies without Gly-Pro (mean ± SD, n = 3).
| Compound | Cytosine (%) | Gemcitabine (%) | Prodrug (%) |
|---|---|---|---|
| Gemcitabine | 50 | 50 | |
| 5′-L-Phenylalanyl- gemcitabine | 0 | 18 | 82 |
| 5′-D-Phenylalanyl- gemcitabine | 0 | 31 | 69 |
| 5′-L-Valyl-gemcitabine | 0 | 15 | 85 |
| 5′-D-Valyl-gemcitabine | 0 | 10 | 90 |